Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc > News Release: Further information…
View:
Post by MirrorWorldMan on Nov 03, 2022 2:19pm

News Release: Further information…

"The FDA goal to make a MDUFA Decision for a 510(k) is 90 FDA Days. FDA Days are calculated as the number of calendar days between the date the 510(k) was received and the date of a MDUFA decision, excluding the days the submission was on hold for an AI request. MDUFA Decisions for 510(k) submissions include findings of substantially equivalent (SE) or not substantially equivalent (NSE)."
Comment by francoisl13 on Jan 27, 2023 10:28am
The FDA site is updated every Monday (see lik below); CRDH 510k Approval database Based on KNE submitting their file in October and info provided by MirroWorldMan, I expect the coactiv+ approval to be published on Monday January 30th (earliest) or February 6th. GLTA
Comment by RoyMax123 on Jan 27, 2023 1:00pm
someone posted this on CEO https://ceo.ca/kne?af99af499987  So I think we'll have to wait a bit more.
Comment by RoyMax123 on Jan 27, 2023 1:04pm
BTW, He also posted that vids, listen at around 2Min https://www.paidpromotionalmessages.com/companies/news/1004091/kane-biotech-announces-distribution-agreement-for-coactiv-antimicrobial-hydrogel-1004091.htm
Comment by francoisl13 on Mar 16, 2023 3:23pm
New video from Mr. Edwards talking about the upcoming catalysts for the company. Based on timing, I expect the 501k for coactiv+ to be approved next week (should know by Monday morning) by the FDA. This will triger a serie of good news from KNE. GLTA.
Comment by MirrorWorldMan on Mar 16, 2023 11:21pm
I read closely the details of 1year $5M credit facility from Pivot. The repayment terms are brutal, including an immediate repayment of $1M after an offering or equity investment, 15% interest rate, $1M Guarantor requirements and 2.5 M x .10 warrants. That is a desperate bridge financing and tremendous anticipation of revenue within one year. It is highly unlikely that Marc Edwards, averse to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities